TrialDiabetes/metabolism research and reviews2014

Profound defects in β-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the Early Diabetes Intervention Program (EDIP).

Tamara S Hannon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.